Indo Rama Synthetics India posts Q1 FY23 PAT at Rs. 38.61 Cr
The company has reported total income of Rs. 1179.13 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 1179.13 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 249.53 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 525.01 crores during the period ended June 30, 2022.
BPCL has reported Revenue from Operations of Rs 1,38,405.79 crores for the quarter April-June 2022 Vs Rs.89,688.98 Crs in the corresponding comparative quarter.
Focus on areas like hydrogen in the energy transition, carbon capture and storage, accessible solar power, plastic recycling, and cheap energy storage
Few R&D projects have also been undertaken by OGPSUs using green hydrogen for fuel cell based mobility
The 2G Ethanol Plant has been built at an estimated cost of over Rs. 900 crore by Indian Oil Corporation Ltd. (IOCL) and is located close to the Panipat Refinery
The urea melt plant with a pool reactor will use Stamicarbon’s MP Flash Design which is part of the LAUNCH MELT series and the Fluid bed Granulation design including acidic scrubbing which is part of the LAUNCH FINISH series
The Committee will examine different options and also engage the services of experts such as lawyers, financial advisors, valuer, merchant banker, etc. as may be required and submit its recommendations to the board for consideration
Once authorized and completed, the plant will process 256,000 tons/year of non-recyclable waste and will produce 125,000 tons/year of Methanol and 1,400 tons/year of Hydrogen
Direct-C has developed a sophisticated sensor technology for the early detection of hydrocarbon leakages
Restart of work on mega project postponed to allow time for investigation and additional social compliance measures
APIC is a contract development and manufacturing organization (CDMO) that offers a wide range of services such as synthetic route design, pilot manufacturing, investigational medical manufacturing, and commercial production, by making full use of integrated processes that combine organic synthesis technologies and biotechnologies it has cultivated over many years
Profit after Tax (PAT) was up 18% for Q1 FY23 to reach Rs. 28.7 crore whereas EBITDA was up 52% to reach Rs. 57.7 crore
The strong topline performance was driven by incremental benefits accruing from the expanded capacity and was supported by continued positive demand across key products
The company is planning a Capex outflow of Rs. 70 crore for FY23 which will target further increase Sandila plant capacity by 4,000 MT
The expansion program is on due course and will see additional capacity going onstream in batches starting from the second half of 2023 to 2023
Baroda plant to be commissioned by June 2023, Mahad plant by H1 2023, and Bareilly plant by October 2022
Both the plants have a total Capex of Rs. 75 crore and expected production timeline is Q3 FY23
The brownfield expansion to introduce a new speciality chemical to aid Barium portfolio diversification is on track and is expected to be commissioned by H1 FY24
Subscribe To Our Newsletter & Stay Updated